AT
Aristea Therapeutics
Aristea Therapeutics develops targeted biologic therapies for autoimmune diseases by utilizing advanced monoclonal antibody technology to modulate immune responses. The company focuses on addressing the unmet medical needs of patients suffering from chronic inflammatory conditions, aiming to improve treatment efficacy and patient outcomes.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Aristea Therapeutics develops targeted biologic therapies for autoimmune diseases by utilizing advanced monoclonal antibody technology to modulate immune responses. The company focuses on addressing the unmet medical needs of patients suffering from chronic inflammatory conditions, aiming to improve treatment efficacy and patient outcomes.